PATENT CLAIM ANALYSIS

Application Number: 16235210
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "345000"]

Abstract:
Provided herein is a combination therapy comprising a compound of Formula I and peginterferon alfa-2a, or another interferon analog. The combination therapy is useful for the treatment of HBV infection. Also provided herein are compositions comprising a compound of Formula I and peginterferon alfa-2a, or another interferon analog.

Claim (Index 12):
The method of  claim 6 , wherein the treatment comprises administering the peginterferon alfa-2a and compound of Formula I at different times.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 98.0
- Lexical Diversity: 1.70968
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14541487', '15671499', '14801126', '15284807', '15612240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.825659490069161
- 35 USC 102 Novelty (BERT): 0.522189037434107
- Combined Prediction Score: 0.7953124448056557
- Mean Citation Score: 342.23141
- Max Citation Score: 345.6282
- Similarity Product: 227.25642268663643

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test